Contipro a.s. Company Profile,Contipro a.s. Essential Information

Company Profile

Our Company Our Business

Year Established : 1990

Total Assets(USD) : 500,000 to 99,999,999

Total Number of Staff : 100-500

Main Competitive Advantages : Brand Name,Experienced R&D Staff,Buyers' Specifications Accepted,Reputation,Quality Service

Other Competitive Advantages : Fully integrated production process (fermentation, purification, modification) with EU-based GMP-certified facilities. Customized HA grades, broad molecular weight range, and functional derivatives available. Strong regulatory support and long-term global supply reliability.

Patents and Copyrights : Contipro holds over 130 patents and utility models in the field of hyaluronic acid and biomedical applications. Our research team actively contributes to scientific advancement with approximately 20 peer-reviewed publications annually, focusing on drug delivery, tissue engineering, and HA modifications. We continuously invest in R&D to protect novel processes, functional derivatives, and application-specific formulations.

Send Inquiry

Contipro a.s.
Contact Person : Ms Jana Mikyskova
Tel: Click to View
Fax: --

Contipro a.s. is a leading Czech biotechnology company specialized in the research, development, and production of hyaluronic acid and its derivatives for pharmaceutical, cosmetic, and medical applications.

With over 30 years of experience, Contipro combines state-of-the-art manufacturing with in-house R&D and a strong commitment to innovation, quality, and sustainability.

Our pharmaceutical-grade HA products are used worldwide in injectable formulations, wound healing, ophthalmology, tissue engineering, and dermatology. We support both industrial partners and academic researchers with high-purity HA tailored to specific needs.

Contipro exports to more than 70 countries and is recognized as a reliable supplier with deep scientific expertise, full traceability, and excellent technical support.

Company Profile of Contipro a.s.

Company Profile